Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021.
Corporate Participants:
Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions
Robert B. Ford — President and Chief Executive Officer
Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer
Analysts:
Bob Hopkins — Bank of America Merrill Lynch — Analyst
Matthew Taylor — UBS — Analyst
Robert Marcus — J.P. Morgan — Analyst
David Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo — Analyst
Joanne Wuensch — Citi — Analyst
Vijay Kumar — Evercore ISI — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,